{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:32:05Z","timestamp":1792679525843,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.neuropharm.2005.08.016","type":"journal-article","created":{"date-parts":[[2005,10,13]],"date-time":"2005-10-13T13:45:49Z","timestamp":1129211149000},"page":"98-110","source":"Crossref","is-referenced-by-count":39,"title":["Stereoselective effects of the novel anticonvulsant lacosamide against 4-AP induced epileptiform activity in rat visual cortex in vitro"],"prefix":"10.1016","volume":"50","author":[{"given":"George","family":"Lees","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"St\u00f6hr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam C.","family":"Errington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.neuropharm.2005.08.016_bib3","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/S0968-0896(99)00186-8","article-title":"The anticonvulsant activities of N-benzyl 3-methoxypropionamides","volume":"7","author":"Andurkar","year":"1999","journal-title":"Bioorganic & Medicinal Chemistry"},{"issue":"3","key":"10.1016\/j.neuropharm.2005.08.016_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1528-1157.2001.042suppl.3002.x","article-title":"Do interictal discharges promote or control seizures? Experimental evidence from an in vitro model of epileptiform discharge","volume":"42","author":"Avoli","year":"2001","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.neuropharm.2005.08.016_bib5","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1523\/JNEUROSCI.16-12-03912.1996","article-title":"Synchronous GABA-mediated potentials and epileptiform discharges in the rat limbic system in vitro","volume":"16","author":"Avoli","year":"1996","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"3","key":"10.1016\/j.neuropharm.2005.08.016_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0301-0082(02)00077-1","article-title":"Network and pharmacological mechanisms leading to epileptiform synchronization in the limbic system in vitro","volume":"68","author":"Avoli","year":"2002","journal-title":"Progress in Neurobiology"},{"issue":"23","key":"10.1016\/j.neuropharm.2005.08.016_bib7","doi-asserted-by":"crossref","first-page":"9308","DOI":"10.1523\/JNEUROSCI.17-23-09308.1997","article-title":"CA3-driven hippocampal\u2013entorhinal loop controls rather than sustains in vitro limbic seizures","volume":"17","author":"Barbarosie","year":"1997","journal-title":"The Journal of Neuroscience: The Official Journal of the Society for Neuroscience"},{"issue":"1","key":"10.1016\/j.neuropharm.2005.08.016_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0306-4522(03)00262-8","article-title":"Involvement of amygdala networks in epileptiform synchronization in vitro","volume":"120","author":"Benini","year":"2003","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2005.08.016_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0920-1211(02)00106-7","article-title":"Progress report on new antiepileptic drugs: a summary of the sixth Eilat conference (EILAT VI)","volume":"51","author":"Bialer","year":"2002","journal-title":"Epilepsy Research"},{"issue":"1","key":"10.1016\/j.neuropharm.2005.08.016_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0006-8993(99)02348-3","article-title":"Effects of standard anticonvulsant drugs on different patterns of epileptiform discharges induced by 4-aminopyridine in combined entorhinal cortex\u2013hippocampal slices","volume":"859","author":"Bruckner","year":"2000","journal-title":"Brain Research"},{"issue":"9","key":"10.1016\/j.neuropharm.2005.08.016_bib11","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1021\/jm9508705","article-title":"Synthesis and anticonvulsant activities of N-benzyl-2-acetamidopropionamide derivatives","volume":"39","author":"Choi","year":"1996","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.neuropharm.2005.08.016_bib12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/BF00580998","article-title":"A thin slice preparation for patch clamp recordings from neurones of the mammalian central nervous system","volume":"414","author":"Edwards","year":"1989","journal-title":"Pflugers Archiv: European Journal of Physiology"},{"issue":"3","key":"10.1016\/j.neuropharm.2005.08.016_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0920-1211(92)90075-5","article-title":"Effects of antiepileptic drugs on 4-aminopyridine-induced epileptiform activity in young and adult rat hippocampus","volume":"12","author":"Fueta","year":"1992","journal-title":"Epilepsy Research"},{"issue":"3","key":"10.1016\/j.neuropharm.2005.08.016_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/hipo.450040317","article-title":"Synaptic and intrinsic properties of neurons of origin of the perforant path in layer II of the rat entorhinal cortex in vitro","volume":"4","author":"Jones","year":"1994","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2005.08.016_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4684-5769-8_21","article-title":"Spontaneous and evoked NMDA-receptor mediated potentials in the entorhinal cortex of the neonate rat in vitro","volume":"268","author":"Jones","year":"1990","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"1","key":"10.1016\/j.neuropharm.2005.08.016_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0163-7258(01)00122-X","article-title":"The mechanisms of action of commonly used antiepileptic drugs","volume":"90","author":"Kwan","year":"2001","journal-title":"Pharmacology & Therapeutics"},{"issue":"1","key":"10.1016\/j.neuropharm.2005.08.016_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1113\/jphysiol.2002.015933","article-title":"Fast network oscillations induced by potassium transients in the rat hippocampus in vitro","volume":"542","author":"LeBeau","year":"2002","journal-title":"The Journal of Physiology"},{"issue":"10","key":"10.1016\/j.neuropharm.2005.08.016_bib20","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1016\/S0968-0896(01)00204-8","article-title":"Functionalized amino acid anticonvulsants: synthesis and pharmacological evaluation of conformationally restricted analogues","volume":"9","author":"LeTiran","year":"2001","journal-title":"Bioorganic & Medicinal Chemistry"},{"issue":"Pt 3","key":"10.1016\/j.neuropharm.2005.08.016_bib21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1469-7793.1998.785bm.x","article-title":"Laminar organization of epileptiform discharges in the rat entorhinal cortex in vitro","volume":"509","author":"Lopantsev","year":"1998","journal-title":"The Journal of Physiology"},{"issue":"1","key":"10.1016\/j.neuropharm.2005.08.016_bib22","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1152\/jn.1998.79.1.352","article-title":"Participation of GABAA-mediated inhibition in ictallike discharges in the rat entorhinal cortex","volume":"79","author":"Lopantsev","year":"1998","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.neuropharm.2005.08.016_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0014-4886(64)90026-3","article-title":"Cortical cellular phenomena in experimental epilepsy: ictal manifestations","volume":"9","author":"Matsumoto","year":"1964","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.neuropharm.2005.08.016_bib25","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"issue":"4","key":"10.1016\/j.neuropharm.2005.08.016_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1152\/jn.1991.65.4.771","article-title":"Physiology and pharmacology of epileptiform activity induced by 4-aminopyridine in rat hippocampal slices","volume":"65","author":"Perreault","year":"1991","journal-title":"Journal of Neurophysiology"},{"issue":"1","key":"10.1016\/j.neuropharm.2005.08.016_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0165-3806(96)00040-5","article-title":"Developmental features of 4-aminopyridine induced epileptogenesis","volume":"94","author":"Psarropoulou","year":"1996","journal-title":"Developmental Brain Research"},{"issue":"1","key":"10.1016\/j.neuropharm.2005.08.016_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0165-0173(97)00054-4","article-title":"Sodium channels as molecular targets for antiepileptic drugs","volume":"26","author":"Ragsdale","year":"1998","journal-title":"Brain Research Reviews"},{"issue":"6197","key":"10.1016\/j.neuropharm.2005.08.016_bib29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/336379a0","article-title":"Temporal integration by a slowly inactivating K+ current in hippocampal neurons","volume":"336","author":"Storm","year":"1988","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neuropharm.2005.08.016_bib30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0006-8993(82)90423-1","article-title":"Effect of 4-aminopyridine on transmitter release in synaptosomes","volume":"250","author":"Tapia","year":"1982","journal-title":"Brain Research"},{"issue":"6","key":"10.1016\/j.neuropharm.2005.08.016_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0301-0082(98)00020-3","article-title":"Gamma-frequency oscillations: a neuronal population phenomenon, regulated by synaptic and intrinsic cellular processes, and inducing synaptic plasticity","volume":"55","author":"Traub","year":"1998","journal-title":"Progress in Neurobiology"},{"issue":"1","key":"10.1016\/j.neuropharm.2005.08.016_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00583659","article-title":"Block of potassium channels of the nodal membrane by 4-aminopyridine and its partial removal on depolarization","volume":"367","author":"Ulbricht","year":"1976","journal-title":"Pflugers Archiv: European Journal of Physiology"},{"issue":"2","key":"10.1016\/j.neuropharm.2005.08.016_bib33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0163-7258(00)00038-3","article-title":"Neuronal fast oscillations as a target site for psychoactive drugs","volume":"86","author":"Whittington","year":"2000","journal-title":"Pharmacology & Therapeutics"},{"issue":"5","key":"10.1016\/j.neuropharm.2005.08.016_bib34","first-page":"549","article-title":"Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells","volume":"27","author":"Willow","year":"1985","journal-title":"Molecular Pharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2005.08.016_bib35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0306-4522(01)00622-4","article-title":"Laminar properties of 4-aminopyridine-induced synchronous network activities in rat neocortex","volume":"111","author":"Yang","year":"2002","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.neuropharm.2005.08.016_bib39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1528-1157.2002.51401.x","article-title":"Neocortical potassium currents are enhanced by the antiepileptic drug lamotrigine","volume":"43","author":"Zona","year":"2002","journal-title":"Epilepsia"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390805003229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390805003229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,31]],"date-time":"2019-03-31T02:19:48Z","timestamp":1553998788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390805003229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0028390805003229"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2005.08.016","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}